Kuppuswamy Nagarajan

Title: Kuppuswamy Nagarajan: Innovator in Pharmaceutical Patents

Introduction

Kuppuswamy Nagarajan is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, holding a total of five patents. His work focuses on developing innovative compounds and methods that address various health challenges.

Latest Patents

One of his latest patents is for a compound titled 3-(5-methyl-2-oxo-l, 3-dioxol-4-yl) methyloxy-2-trans-[(4-chloro phenyl) cyclohexyl][1,4]naphthaquinone-atovaquone prodrug. This invention relates to an atovaquone prodrug compound, providing a process that involves the condensation of Atovaquone with 5-methyl-4-chloromethyl dioxalone in a suitable solvent system. The process is designed to yield high purity and is suitable for large-scale manufacture. Another significant patent involves flavivirus inhibitors and methods of their use. This patent discloses methods for treating, preventing, and ameliorating infections caused by viruses such as West Nile Virus, Dengue Virus, and Japanese Encephalitis Virus through the administration of a therapeutically effective amount of a serine protease inhibitor.

Career Highlights

Kuppuswamy Nagarajan has worked with prominent organizations, including Alkem Laboratories Limited and Georgetown University. His experience in these institutions has contributed to his expertise in pharmaceutical research and development.

Collaborations

He has collaborated with notable coworkers such as Shashiprabha and Radhakrishnan Padmanabhan, further enhancing his research capabilities and innovation potential.

Conclusion

Kuppuswamy Nagarajan is a distinguished inventor whose work in pharmaceuticals has led to valuable patents that address critical health issues. His contributions continue to impact the field positively.